Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes. | Inflamm Res | 2023 | 37507570 | PubTator, text mining | PubMed |
| Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial. | JAMA Netw Open | 2023 | 37490292 | PubTator, text mining | PubMed |
| Full-length transcript alterations in human bronchial epithelial cells with U2AF1 S34F mutations. | Life Sci Alliance | 2023 | 37487637 | PubTator, text mining | PubMed |
| Prediction of risk for myeloid malignancy in clonal hematopoiesis. | NEJM Evid | 2023 | 37483562 | PubTator, text mining | PubMed |
| Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). | Biomater Res | 2023 | 37480049 | PubTator, text mining | PubMed |
| Computational analysis of peripheral blood smears detects disease-associated cytomorphologies. | Nat Commun | 2023 | 37474506 | PubTator, text mining | PubMed |
| Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm. | Blood Cancer J | 2023 | 37460550 | PubTator, text mining | PubMed |
| Differential diagnoses and the mutational landscape of myelodysplastic/myeloproliferative neoplasm with neutrophilia: A case report. | Mol Clin Oncol | 2023 | 37456801 | PubTator, text mining | PubMed |
| Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome. | Blood Adv | 2023 | 37450374 | PubTator, text mining | PubMed |
| Histone Variants and Their Chaperones in Hematological Malignancies. | Hemasphere | 2023 | 37449197 | PubTator, text mining | PubMed |
| Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. | Cancers (Basel) | 2023 | 37444622 | PubTator, text mining | PubMed |
| Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments. | Cancers (Basel) | 2023 | 37444441 | PubTator, text mining | PubMed |
| Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022. | Cancers (Basel) | 2023 | 37444402 | PubTator, text mining | PubMed |
| Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms. | Cancers (Basel) | 2023 | 37444390 | PubTator, text mining | PubMed |
| Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia. | Blood | 2023 | 37441846 | PubTator, text mining | PubMed |
| Chronic neutrophilic leukemia preceded by myelodysplastic syndromes. | Int J Hematol | 2023 | 37439996 | PubTator, text mining | PubMed |
| The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients. | Front Med (Lausanne) | 2023 | 37435533 | PubTator, text mining | PubMed |
| Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. | J Hematol | 2023 | 37435412 | PubTator, text mining | PubMed |
| TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia. | Mediterr J Hematol Infect Dis | 2023 | 37435040 | PubTator, text mining | PubMed |
| Evaluation of hypereosinophilia in a case of FLT3-mutant acute myeloid leukemia treated with gilteritinib. | Cold Spring Harb Mol Case Stud | 2023 | 37433680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=22